Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer. (Q39709734)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer. |
scientific article |
Statements
Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer (English)
Koichi Goto
Yukito Ichinose
Yuichiro Ohe
Nobuyuki Yamamoto
Shunichi Negoro
Kazuto Nishio
Yohji Itoh
Haiyi Jiang
Emma Duffield
Rose McCormack
Nagahiro Saijo
Masahiro Fukuoka
1 January 2012